Impact of high-dose quinapril versus low-dose quinapril plus amlodipine on autonomic regulation and on sympathetic activation in response to cold exposure in hypertensive patients with impaired glucose tolerance, diabetes or coronary artery disease

Trial Profile

Impact of high-dose quinapril versus low-dose quinapril plus amlodipine on autonomic regulation and on sympathetic activation in response to cold exposure in hypertensive patients with impaired glucose tolerance, diabetes or coronary artery disease

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 05 May 2008

At a glance

  • Drugs Amlodipine; Quinapril
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 May 2008 Trial discontinued due to slow recruitment- 2 patioents in nearly 2 years, according to clinicaltrials.gov record.
    • 05 May 2008 Status changed from recruiting to discontinued according to clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top